Received Jul 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 4 | md3414 | IM / LA |
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | N/A | jb27a | IM / LA |
Pt has not reported any adverse effects, however the dose of Arexvy was unnecessary. Patient previously received a single dose of Arexvy on03/24/2024, making this an extraneous dose
n/a
n/a
n/a
n/a
None